Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats -: Comparison with PPAR-γ activation

被引:299
作者
Ye, JM
Doyle, PJ
Iglesias, MA
Watson, DG
Cooney, GJ
Kraegen, EW
机构
[1] Garvan Inst Med Res, Sydney, NSW, Australia
[2] Novo Nordisk AS, Bagsverd, Denmark
关键词
D O I
10.2337/diabetes.50.2.411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator-activated receptor (PPAR)-alpha agonists lower circulating lipids, but the consequences for muscle lipid metabolism and insulin sensitivity are not clear. We investigated whether PPAR-alpha activation improves insulin sensitivity in insulin-resistant rats and compared the effects with PPAR-gamma activation. Three-week high fat-fed male Wistar rats we're untreated or treated with the specific PPAR-a agonist WY14643 or the PPAR-gamma agonist pioglitazone (both 3 mg . kg(-1). day(-1)) for the last 2 weeks of high-fat feeding. Like pioglitazone, WY14643 lowered basal plasma levels of glucose, triglycerides (-16% vs. untreated), and leptin (-52%), and also muscle triglyceride (-34%) and total long-chain acyl-CoAs (LCACoAs) (-41%) (P < 0.05). In contrast to pioglitazone, WY14643 substantially reduced visceral fat weight and total liver triglyceride content (P < 0.01) without increasing body weight gain. WY14643 and pioglitazone similarly enhanced whole-body insulin sensitivity (clamp glucose infusion rate increased 35 and 37% and glucose disposal 22 and 15%, respectively, vs. untreated). Both agents enhanced insulin-mediated muscle glucose metabolic index (Rg') and reduced muscle triglyceride and LCACoA accumulation (P < 0.05). Although pioglitazone had more potent effects than WY14643 on muscle insulin sensitization, this was associated with its greater effect to reduce muscle LCACoA accumulation. Overall insulin-mediated muscle Rg' was inversely correlated with the content of LCACoAs (r = -0.74, P = 0.001) and with plasma triglyceride levels (r = -0.77, P < 0.001). We conclude that even though WY14643 and pioglitazone, representing PPAR-alpha and PPAR-gamma activation, respectively may alter muscle lipid supply by different mechanisms, both significantly improve muscle insulin action in the high fat-fed rat model of insulin resistance, and this effect is proportional to the degree to which they reduce muscle lipid accumulation.
引用
收藏
页码:411 / 417
页数:7
相关论文
共 41 条
[21]  
KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353
[22]   Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay [J].
Krey, G ;
Braissant, O ;
LHorset, F ;
Kalkhoven, E ;
Perroud, M ;
Parker, MG ;
Wahli, W .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (06) :779-791
[23]   Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat [J].
Laybutt, DR ;
Schmitz-Peiffer, C ;
Saha, AK ;
Ruderman, NB ;
Biden, TJ ;
Kraegen, EW .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (06) :E1070-E1076
[24]   Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action [J].
Loviscach, M ;
Rehman, N ;
Carter, L ;
Mudaliar, S ;
Mohadeen, P ;
Ciaraldi, TP ;
Veerkamp, JH ;
Henry, RR .
DIABETOLOGIA, 2000, 43 (03) :304-311
[25]   The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM [J].
Markovic, TP ;
Jenkins, AB ;
Campbell, LV ;
Furler, SM ;
Kraegen, EW ;
Chisholm, DJ .
DIABETES CARE, 1998, 21 (05) :687-694
[26]   Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPAR alpha and PPAR gamma activators [J].
Martin, G ;
Schoonjans, K ;
Lefebvre, AM ;
Staels, B ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28210-28217
[27]   Improved insulin sensitivity by bezafibrate in rats - Relationship to fatty acid composition of skeletal-muscle triglycerides [J].
Matsui, HR ;
Okumura, K ;
Kawakami, K ;
Hibino, M ;
Toki, Y ;
Ito, T .
DIABETES, 1997, 46 (03) :348-353
[28]   Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPARα) [J].
Meyer, K ;
Völkl, A ;
Endele, R ;
Kühnle, HF ;
Pill, J .
ARCHIVES OF TOXICOLOGY, 1999, 73 (8-9) :440-450
[29]   Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients [J].
Mussoni, L ;
Mannucci, L ;
Sirtori, C ;
Pazzucconi, F ;
Bonfardeci, G ;
Cimminiello, C ;
Notarbartolo, A ;
Scafidi, V ;
Bon, GB ;
Alessandrini, P ;
Nenci, G ;
Parise, P ;
Colombo, L ;
Piliego, T ;
Tremoli, E .
ATHEROSCLEROSIS, 2000, 148 (02) :397-406
[30]   The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat [J].
Oakes, ND ;
Camilleri, S ;
Furler, SM ;
Chisholm, DJ ;
Kraegen, EW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (08) :935-942